• 대한기관식도과학회지
• /
• 제15권2호
• /
• pp.49-56
• /
• 2009

Purpose : To evaluate the treatment outcome for patients with locally advanced, unresectable esophageal cancer treated with relatively high dose radiation therapy(RT). Materials and Methods : From January 2000 to December 2008, 32 patients with locally advanced unresectable or medically inoperable esophageal cancer were treated with radiation therapy(RT) with or without concurrent chemotherapy. Ten patients were excluded from analysis because of distant metastasis and drop off. Patient distributions according to AJCC stages II, III IVa were 7(31.8%), 12(54.6%), 3(13.6%) respectively. The locations of tumor were cervical/upper thorax 3 (13.6%), mid thorax 13(59.1%), and lower thorax/abdominal 6(27.3%), respectively. Eleven patients received RT only, and 11 patients received cisplatin based concurrent chemoradiotherapy(CCRT). Median radiation dose was 65 Gy(range 57.6~72 Gy). Results : The median follow-up was 9.1 months(range 1.9~43.8 months). The response rates for complete response, Partial response, stable disease and Persistent disease were 6(27.3%), 11(50.0%), 4(18.2%) and 1(4.5%), respectively. Two patients(9.1%) suffered from esophageal stenosis and stents were inserted. Two patients(9.1%) had Grade 3 radiation pneumonitis and one of them expired due to acute respiratory distress syndrome(ARDS) at 36 days after completion of radiation therapy. The recurrence rate was 11(50.0%). The patterns of recurrence were persistent disease and local progression in 5(22.7%), local recurrence 3(13.7%) and concomitant local and distant recurrence in 3(13.7%). The overall survival(OS) rate was 32.1% at 2 years and 21.4% at 3 years(median 12.0 months). Disease free survival(DFS) rate was 17.3% at 2 and 3 years. All patients who had no dysphagia at diagnosis showed complete response after treatment and 100% OS at 3 years(p=0.0041). The OS for above 64.8 Gy group and 64.8 Gy or below group at 3 years were 60.6% and 9.1%(p=0.1341). The response to treatment was the only significant factor affecting OS(p=0.004). Conclusion : Relatively high dose radiation therapy in unresectable esophageal cancer tended to have a better outcome without increased complication rate. Further study with more patients is warranted to justify improved result.

• 한국의학물리학회지:의학물리
• /
• 제14권2호
• /
• pp.74-80
• /
• 2003

본 연구의 목적은 핵의학 분야에서 생체 내 흡수선량의 직접 측정에 사용될 수 있는, 테프론을 씌운 TLD의 수행성을 알아보고, 흡수선량 측정 시 테프론의 영향에 대하여 분석하고자 한다. 테프론 캡슐에 든 LiF TLD-100의 반응감도를 고체 팬텀 내에서의 깊이를 달리 하며 측정하였다 성인 인체모형 팬텀을 이용하여 테프론을 씌운 TLD로써 생체 내 흡수선량을 측정하였다. 테프론을 씌우지 않은 보통의 TLD를 이용하여 구한 PDD, TMR, 그리고 생체흡수선량과 테프론을 씌운 TLD로 구한 값을 비교하였다. 보통의 TLD를 이용하여 구한 반응값과 테프론을 씌운 TLD로 구한 값의 차이는 build-up이상의 깊이에서는 같은 조건하에서 3％ 이내였다. 그러나 팬텀 표면 부근에서는 테프론 켑슐의 두께에 기인한 build-up 효과로 인해 큰 차이를 보였다. 본 연구에서 테프론 켑슐로 인하여 수 메가볼트의 방사선에 대한 TLD의 흡수선량 측정에 미치는 변화는 미미한 것으로 나타났다. 따라서 치료 환경 하에서 테프론을 씌운 TLD가 생체 내 선량측정에 매우 적합한 것으로 사료된다.

• IMMUNE NETWORK
• /
• 제6권2호
• /
• pp.93-101
• /
• 2006

Background: Memory T lymphocytes of the immune system provide long-term protection in response to bacterial or viral infections/immunization. Ag concentration has also been postulated to be important in determining whether T cell differentiation favors effector versus memory cell development. In the present study we hypothesized that naive Ag-specific $CD4^+$ T cells briefly stimulated with different Ag doses at the primary exposure could affect establishment of memory cell pool after secondary immunization. Methods: To assess this hypothesis, the response kinetics of DO11.10 TCR $CD4^+$ T cells primed with different Ag doses in vitro was measured after adoptive transfer to naive BALB/c mice. Results: Maximum expansion was shown in cells primarily stimulated with high doses of ovalbumin peptide $(OVA_{323-339})$, whereas cells in vitro stimulated with low dose were expanded slightly after in vivo secondary exposure. However, the cells primed with low $OVA_{323-339}$ peptide dose showed least contraction and established higher number of memory cells than other treated groups. When the cell division was analyzed after adoptive transfer, the high dose Ag-stimulated donor cells have undergone seven rounds of cell division at 3 days post-adoptive transfer. However, there was very few division in naive and low dose of peptide-treated group. Conclusion: These results suggest that primary stimulation with a low dose of Ag leads to better memory $CD4^+$ T cell generation after secondary immunization. Therefore, these facts imply that optimally primed $CD4^+$ T cells is necessary to support effective memory pool following administration of booster dose in prime-boost vaccination.

• 한국환경성돌연변이발암원학회지
• /
• 제22권2호
• /
• pp.97-105
• /
• 2002

Nowadays a huge variety of products that aim to assist to quit smoking or reduce addictive symptoms are developed and manufactured with safety evaluation, but the safety of the most recent products of interest which do not contain tobacco and nicotine, and shape cigarettes is not evaluated and guaranteed relatively. This study was carried out to evaluate the single and repeated dose inhalation toxicity and genotoxicity of H menthol (Nicotine free-tobacco free) herbal cigarettes provided by Cigastop Ltd. in ICR mice. In this study, doses which we determined to expose to mice were 40 cigarettes for 6 hours a day to mice in single dose and 20 (high dose), 10 (middle dose) and 5 cigarettes (low dose) a day for 28 days in repeated dose inhalation toxicity, in vivo chromosome aberration test and micronucleus test. The particulate substances from H menthol herbal cigarettes also were gathered and used in the Salmonella typhimurium/microsome assay (Salmonella test; Ames test). We could find neither significant changes between control and treatment groups nor dose-response effects of test material at all except serum Ca level of female middle dose treatment group in repeated dose inhalation toxicity test. In conclusion, H menthol herbal cigarettes, when applied clinically intended dose we used, might not show any toxic and/or mutagenic effect.

• 한국환경보건학회지
• /
• 제49권1호
• /
• pp.1-10
• /
• 2023

Low-dose radiation exposure has received considerable attention because it reflects the general public's type and level of exposure. Still, controversy remains due to the relatively unclear results and uncertainty in risk estimation compared to high-dose radiation. However, recent epidemiological studies report direct evidence of health effects for various types of low-dose radiation exposure. In particular, international nuclear workers' studies, CT exposure studies, and children's cancer studies on natural radiation showed significantly increased cancer risk among the study populations despite their low-dose radiation exposure. These studies showed similar results even when the cumulative radiation dose was limited to an exposure group of less than 100 mGy, demonstrating that the observed excess risk was not affected by high exposure. A linear dose-response relationship between radiation exposure and cancer incidence has been observed, even at the low-dose interval. These recent epidemiological studies include relatively large populations, and findings are broadly consistent with previous studies on Japanese atomic bomb survivors. However, the health effects of low-dose radiation are assumed to be small compared to the risks that may arise from other lifestyle factors; therefore, the benefits of radiation use should be considered at the individual level through a balanced interpretation. Further low-dose radiation studies are essential to accurately determining the benefits and risks of radiation.

• Radiation Oncology Journal
• /
• 제7권1호
• /
• pp.15-22
• /
• 1989

Diethone의 피부에 대한 방사선 보호작용을 평가하기 위하여 Wistar계 랫드에 단일 X-선(20, 30, 40 Gy) 조사 후 시간경과와 선량변화에 따른 급성 피부반응을 연구하였다. 40Gy 선량에서 Diethone군의 피부반응기간은 24.7일로 대조군(29.8일)과 바셀린(29.2일) 투여군에 비하여 약$17\%$의 피부반응 기간이 뚜렷이 감소되었다. 피부반응이 최고도에 달한 10일 동안의 평균치는 Diethone군(2.43)이 대조군(2.91)과 바셀린(2.81)군에 비하여 현저히 감소되었다. 피부반응 Score 2.5에서 구한 등가효과 선량의 반응감소 계수(DRF)는 1.41로 피부보호효과가 있었다. 본 실험 결과로 보아 방사선 피부보호제를 국소적으로 도포함으로써 일반적인 치료선량보다 많은 방사선량을 거대하고 방사선내성이 있는 종양에 조사함으로로써 치료효과를 향상시킬 수 있을 것으로 기대한다.

• 한국잡초학회지
• /
• 제32권3호
• /
• pp.159-169
• /
• 2012

일부 화학물질은 고농도에서 독성을 나타내지만 낮은 농도에서는 촉진되거나 유익하게 이용될 수 있는데 이와 같은 양방향 농도반응 현상을 양면성이라고 하며, 많은 제초제와 식물독소에서 볼 수 있다. 양면성 농도반응은 동물, 식물, 미생물을 포함하는 모든 생물체에서 일반적으로 볼 수 있다. 이 현상은 동물과 포유동물에서 가장 관심이 많았으나 식물에서는 관심이 적었다. 2,4-D, metribuzin, bromacil, bromoxynil, chloramben, propachlor, terbacil, EPTC, MSMA, glyphosate, metsulfuron, acifluorfen, terbuthylazine는 저농도에서 양면성 촉진반응을 나타냈다. Metsulfuron과 glyphosate는 아미노산 생합성에 양면성 반응을 나타냈고, terbacil과 simazine은 단백질 함량을 증가시켰다. 그리고 acifluorfen과 terbuthylazine의 양면성 반응은 직접 혹은 간접적으로 아미노산 생합성과 관련된 기작에 의하여 유도 혹은 증대되었다. Sulfentrazone과 lactofen을 처리하면 식물독소 생산을 증가시켜 균핵병 발생을 감소시켰다. 사탕수수에서 glyphosate 저농도 처리에 의한 설탕생산 증가효과는 설탕산업에서 상용화되어 활용되고 있다. 제초제의 생장촉진 반응을 나타내는 요인들에 대하여는 많이 밝혀졌으나 양면성의 작용기작에 관한 연구는 극히 제한되었고, 생장촉진을 화학적으로 유기하는 기작은 아직 완전히 밝혀지지 않았다.

• Radiation Oncology Journal
• /
• 제36권3호
• /
• pp.248-253
• /
• 2018

Radiation protection in the scrotum to reduce the risk of genetic effect in the future is very important. This study aimed to measure the scrotal dose outside the treatment fields by using the radio-photoluminescence glass dosimeter (RPLGD). The characteristics of RPLGD model GD-302M were studied. Scattered dose to scrotum was measured in one liposarcoma case with the prescribed dose of 60 Gy. RPLGDs were placed in three different locations: one RPLGD was positioned at the posterior area which closer to the scrotum, and the other two RPLGDs were placed between the penis and the scrotum. Three RPLGDs were employed in each location. The scattered doses were measured in every fraction during the whole course of treatment. The entire number of 100 RPLGDs showed the uniformity within ±2%. The signal from RPLGD demonstrated linear proportion to the radiation dose (r = 0.999). The relative energy response correction factor was 1.05. The average scrotal dose was 4.1 ± 0.9 cGy per fraction. The results presented a wide range since there was a high uncertainty during RPLGD placement. The total scrotal dose for the whole course of treatment was 101.9 cGy (1.7% of the prescribed dose). The RPLGD model GD-302M could be used to measure scattered dose after applying the relative energy correction factor.

• 공업화학
• /
• 제29권3호
• /
• pp.270-277
• /
• 2018

반응 표면법(RSM)과 Box-Behnken 설계(BBD) 통계 방법을 사용하여 폐감귤박으로 만든 활성탄(WCAC)에 의한 염료 Eosin Y의 흡착을 검토하였다. 실험은 Eosin Y의 농도(Conc. : 30~50 mg/L), 용액 온도(Temp. : 293~313 K) 및 흡착제 투여량(Dose : 0.05~0.150 g/L)의 3가지 입력 변수를 가진 BBD에 따라 수행하였다. 염료 Eosin Y 제거에 대해 얻어진 2차 다항식 모델의 회귀분석 결정계수($R^2$) 값이 0.9851이고 적합성 결여(Lack of fit)의 p 값은 0.342로 실험 데이터는 2차 다항식 모델에 잘 부합하였다. 염료 농도 50 mg/L, 온도 333 K 및 흡착제 투여량 0.1056 g에서 최적 염료 흡착량 59.3 mg/g이 얻어졌다. WCAC에 의한 Eosin Y의 흡착공정은 유사 2차 속도식에 의해 잘 기술되었으며, 등온 실험결과는 Langmuir 모델식을 따랐다.

• 한국환경과학회지
• /
• 제26권3호
• /
• pp.345-362
• /
• 2017

The primary purpose of this study was to determine the risk of various disease outcomes due to exposure to cyanobacteria toxin (microcystin-LR) through drinking water in a Korean watershed. In order to determine the risk in a more quantitative way, the risk assessment framework developed by the National Research Council (NRC) of the United States (US) - hazard identification, dose-response relationship, exposure assessment, and risk characterization - was used in this study. For dose-response relationships, a computer software (BenchMark Dose Software (BMDS)) developed by the US Environmental Protection Agency (EPA) was used to fit the data from previous studies showing the relationship between the concentration of microcystin-LR and various disease outcomes into various dose-response models. For exposure assessment, the concentrations of microcystin-LR in the source water and finished water in a Korean watershed obtained from a recent study conducted by the Ministry of Environment of Korea were used. Finally, the risk of various disease outcomes due to exposure to cyanobacteria toxin (microcystin-LR) through drinking water was characterized by Monte-Carlo simulation using Crystall Ball program (Oracle Inc.) for adults and children. The results of this study suggest that the risk of disease due to microcystin-LR toxin through drinking water is very low and it appears that current water treatment practice should be able to protect the public from the harmful effects of cyanobacteria toxin (microcystin-LR) through drinking water.